Skip to main content

Table 1 Study design for the bioequivalence evaluation of levamlodipine

From: Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

Groups

Number of cases

The first period

The second period

Fasted group

12

T a

Rb

12

R

T

Fed group

12

T

R

12

R

T

  1. aT: test formulation, levamlodipine besylate, 5 mg /tablet, 1 tablet;
  2. bR: reference formulation, amlodipine besylate, 10 mg /tablet, 1 tablet
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us